National Institute on Drug Abuse, Rockville, Maryland.
JAMA Psychiatry. 2019 Feb 1;76(2):208-216. doi: 10.1001/jamapsychiatry.2018.3126.
More than 42 000 Americans died of opioid overdoses in 2016, and the fatalities continue to increase. This review analyzes the factors that triggered the opioid crisis and its further evolution, along with the interventions to manage and prevent opioid use disorder (OUD), which are fundamental for curtailing the opioid crisis.
Opioid drugs are among the most powerful analgesics but also among the most addictive. The current opioid crisis, initially triggered by overprescription of opioid analgesics, which facilitated their diversion and misuse, has now expanded to heroin and illicit synthetic opioids (fentanyl and its analogues), the potency of which further increases their addictiveness and lethality. Although there are effective medications to treat OUD (methadone hydrochloride, buprenorphine, and naltrexone hydrochloride), these medications are underused, and the risk of relapse is still high. Strategies to expand medication use and treatment retention include greater involvement of health care professionals (including psychiatrists) and approaches to address comorbidities. In particular, the high prevalence of depression and suicidality among patients with OUD, if untreated, contributes to relapse and increases the risk of overdose fatalities. Prevention interventions include screening and early detection of psychiatric disorders, which increase the risk of substance use disorders, including OUD.
Although overprescription of opioid medications triggered the opioid crisis, improving opioid prescription practices for pain management, although important for addressing the opioid crisis, is no longer sufficient. In parallel, strategies to expand access to medication for OUD and improve treatment retention, including a more active involvement of psychiatrists who are optimally trained to address psychiatric comorbidities, are fundamental to preventing fatalities and achieving recovery. Research into new treatments for OUD, models of care for OUD management that include health care, and interventions to prevent OUD may further help resolve the opioid crisis and prevent it from happening again.
2016 年,超过 42000 名美国人死于阿片类药物过量,且死亡人数仍在不断增加。本综述分析了引发阿片类药物危机及其进一步演变的因素,以及管理和预防阿片类药物使用障碍(OUD)的干预措施,这些措施对于遏制阿片类药物危机至关重要。
阿片类药物是最有效的镇痛药之一,但也是最容易上瘾的药物之一。最初由阿片类镇痛药过度处方引发的当前阿片类药物危机,促成了其转移和滥用,现已扩展到海洛因和非法合成阿片类药物(芬太尼及其类似物),其效力进一步增加了它们的成瘾性和致命性。尽管有有效的药物可用于治疗 OUD(盐酸美沙酮、丁丙诺啡和盐酸纳曲酮),但这些药物的使用不足,且复发风险仍然很高。扩大药物使用和治疗保留的策略包括让更多的医疗保健专业人员(包括精神科医生)参与,并解决合并症问题。特别是,未经治疗的 OUD 患者中普遍存在的抑郁和自杀倾向,如果得不到治疗,会导致复发,并增加过量死亡的风险。预防干预措施包括对精神障碍进行筛查和早期发现,这些障碍会增加物质使用障碍(包括 OUD)的风险。
尽管阿片类药物的过度处方引发了阿片类药物危机,但改善阿片类药物治疗疼痛的处方实践虽然对于解决阿片类药物危机很重要,但已不再足够。与此同时,扩大 OUD 药物治疗的途径并提高治疗保留率的策略,包括更积极地让接受过最佳培训以解决精神科合并症的精神科医生参与进来,对于预防死亡和实现康复至关重要。对 OUD 的新治疗方法、包括医疗保健在内的 OUD 管理护理模式以及预防 OUD 的干预措施的研究可能会进一步帮助解决阿片类药物危机并防止其再次发生。